So if Bristol Myers are going to do a counter bid, I'm guessing it'll be within the next couple of weeks.
Are they likely to push the sp above the $1.75 mark before, so as to make the Merck offer look less attractive?
I've never held a stock during a bidding war, so I'm not really sure how these things normally pan out.
Cheers
Latest clinical trial results, page-15
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)